Expertise in
27
conditions

Dr. Dulcinea D. Quintana

Oncology
University Of New Mexico Hospitals
2211 Lomas Blvd NE, 
Albuquerque, NM 
Clinical Trials:Currently Recruiting for 1 Trial
Offers Telehealth
Expertise in
27
conditions
University Of New Mexico Hospitals
2211 Lomas Blvd NE, 
Albuquerque, NM 

Overview

Dulcinea Quintana is an Oncologist practicing medicine in Albuquerque, New Mexico.

Dr. Quintana is highly rated in 27 conditions, according to our data. Her clinical expertise encompasses Acute Myeloblastic Leukemia without Maturation, Acute Myeloid Leukemia (AML), Multiple Myeloma, and Acute Lymphoblastic Leukemia (ALL).

She is actively involved in clinical research, co-authoring 4 peer reviewed articles and participating in 4 clinical trials.

Specialties

Oncology

Licenses

Internal Medicine in NM

Hospital Affiliations

Unm Hospital

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Western Sky Community Care
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER COMMERCIAL
View 8 Less Insurance Carriers -

Locations

University of New Mexico Hospitals
2211 Lomas Blvd NE, Albuquerque, NM 87106

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Effective Quadruplet Utilization After Treatment Evaluation (EQUATE): A Randomized Phase 3 Trial for Newly Diagnosed Multiple Myeloma Not Intended for Early Autologous Transplantation
Effective Quadruplet Utilization After Treatment Evaluation (EQUATE): A Randomized Phase 3 Trial for Newly Diagnosed Multiple Myeloma Not Intended for Early Autologous Transplantation
Enrollment Status: Recruiting
Publish Date: August 19, 2026
Intervention Type: Other, Biological, Drug
Study Drugs: Bortezomib, Daratumumab and Hyaluronidase-fihj, Dexamethasone, Lenalidomide
Study Phase: Phase 3
Randomized Phase III Trial of Lenalidomide Versus Observation Alone in Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
Randomized Phase III Trial of Lenalidomide Versus Observation Alone in Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
Enrollment Status: Active_not_recruiting
Publish Date: August 04, 2026
Intervention Type: Other, Drug
Study Drug: Lenalidomide
Study Phase: Phase 3
Randomized Phase III Trial of Bortezomib, Lenalidomide, and Dexamethasone (VRd) Versus Carfilzomib, Lenalidomide, and Dexamethasone (CRd) Followed by Limited or Indefinite Duration Lenalidomide Maintenance in Patients With Newly Diagnosed Symptomatic Multiple Myeloma (ENDURANCE)
Randomized Phase III Trial of Bortezomib, Lenalidomide, and Dexamethasone (VRd) Versus Carfilzomib, Lenalidomide, and Dexamethasone (CRd) Followed by Limited or Indefinite Duration Lenalidomide Maintenance in Patients With Newly Diagnosed Symptomatic Multiple Myeloma (ENDURANCE)
Enrollment Status: Active_not_recruiting
Publish Date: September 08, 2025
Intervention Type: Other, Drug
Study Drugs: Bortezomib, Carfilzomib, Dexamethasone, Lenalidomide
Study Phase: Phase 3
A Phase I/II Study of Pomalidomide, Dexamethasone and Ixazomib vs. Pomalidomide and Dexamethasone for Patients With Multiple Myeloma Relapsing on Lenalidomide as Part of First Line Therapy
A Phase I/II Study of Pomalidomide, Dexamethasone and Ixazomib vs. Pomalidomide and Dexamethasone for Patients With Multiple Myeloma Relapsing on Lenalidomide as Part of First Line Therapy
Enrollment Status: Unknown
Publish Date: December 01, 2023
Intervention Type: Drug
Study Drugs: Pomalidomide, Ixazomib, Dexamethasone
Study Phase: Phase 1/Phase 2
View 3 Less Clinical Trials

4 Total Publications

Aggressive lymphoma presenting as dysphagia: A rare cause of dysphagia.
Aggressive lymphoma presenting as dysphagia: A rare cause of dysphagia.
Journal: Clinical case reports
Published: October 24, 2016
Similar Doctors
Expertise in
11
conditions
Expertise in
11
conditions
Referral may be required

University Of New Mexico Ems Consortium

1 University Of New Mexico, 
Albuquerque, NM 
 (0.3 miles away)
505-925-0460
Languages Spoken:
English
See accepted insurances

Carolyn Muller is an Oncologist practicing medicine in Albuquerque, New Mexico. Dr. Muller is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Sertoli-Leydig Cell Tumor, and Testicular Yolk Sac Tumor.

Expertise in
47
conditions
Expertise in
47
conditions
Referral may be required

New Mexico Cancer Center

4901 Lang Ave NE, 
Albuquerque, NM 
 (6.1 miles away)
505-842-8171
Languages Spoken:
English, French, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Annette Fontaine is an Oncologist practicing medicine in Albuquerque, New Mexico. Dr. Fontaine is highly rated in 47 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Familial Colorectal Cancer, Bone Marrow Aspiration, and Salpingo-Oophorectomy. Dr. Fontaine is board certified in American Board Of Internal Medicine. Dr. Fontaine is currently accepting new patients.

Expertise in
11
conditions
Expertise in
11
conditions
Referral may be required

University Of New Mexico Hospitals

2211 Lomas Blvd NE, 
Albuquerque, NM 
 (0.1 miles away)
505-272-1623
Languages Spoken:
English
See accepted insurances

Zoneddy Dayao is an Oncologist practicing medicine in Albuquerque, New Mexico. Dr. Dayao is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and Angiosarcoma.

Frequently Asked Questions about Dr. Dulcinea D. Quintana

How do I make an appointment with Dr. Dulcinea D. Quintana?

You can book an appointment with Dr. Dulcinea D. Quintana by calling their office at 505-272-6225. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Dulcinea D. Quintana a top-rated expert for Acute Myeloblastic Leukemia without Maturation?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Dulcinea D. Quintana is classified as an Distinguished expert for Acute Myeloblastic Leukemia without Maturation, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Dulcinea D. Quintana specialize in?

While Dr. Dulcinea D. Quintana is a Oncology, they have specific expertise in Acute Myeloblastic Leukemia without Maturation, Acute Myeloid Leukemia (AML), and Multiple Myeloma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Dulcinea D. Quintana participate in research or clinical trials?

Yes. Dr. Dulcinea D. Quintana has published 4 articles and abstracts on conditions like Acute Myeloblastic Leukemia without Maturation. You can view a list of Dr. Dulcinea D. Quintana's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Dulcinea D. Quintana accept my insurance?

Dr. Dulcinea D. Quintana accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 505-272-6225 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Quintana's expertise for a condition
ConditionClose
    View All 7 Distinguished Conditions
    View All 20 Advanced Conditions
    View All 44 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile